Augmedix Stock Performance


USD 1.62  0.13  8.72%   

The firm shows a Beta (market volatility) of 1.3569, which signifies a somewhat significant risk relative to the market. Let's try to break down what Augmedix's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Augmedix will likely underperform. Even though it is essential to pay attention to Augmedix historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Augmedix exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Augmedix has an expected return of -0.0153%. Please be advised to confirm Augmedix total risk alpha, as well as the relationship between the downside variance and daily balance of power to decide if Augmedix performance from the past will be repeated at some point in the near future.
Augmedix Performance
0 of 100
Over the last 90 days Augmedix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Augmedix is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more

Augmedix Price Channel

Quick Ratio2.75
Fifty Two Week Low1.4100
Target High Price6.00
Fifty Two Week High6.2200
Target Low Price4.00

Augmedix Relative Risk vs. Return Landscape

If you would invest  180.00  in Augmedix on June 30, 2022 and sell it today you would lose (18.00)  from holding Augmedix or give up 10.0% of portfolio value over 90 days. Augmedix is currently does not generate positive expected returns and assumes 5.6096% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than Augmedix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Augmedix is expected to generate 5.09 times more return on investment than the market. However, the company is 5.09 times more volatile than its market benchmark. It trades about 0.0 of its potential returns per unit of risk. The DOW is currently generating roughly -0.07 per unit of risk.

Augmedix Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Augmedix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Augmedix, and traders can use it to determine the average amount a Augmedix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0027

Good Returns
Average Returns
Small Returns
Negative ReturnsAUGX
Estimated Market Risk
  actual daily
 48 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Augmedix is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Augmedix by adding it to a well-diversified portfolio.

About Augmedix Performance

To evaluate Augmedix Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Augmedix generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Augmedix Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Augmedix market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Augmedix's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.

Things to note about Augmedix

Checking the ongoing alerts about Augmedix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Augmedix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Augmedix Alerts

Equity Alerts and Improvement Suggestions

Augmedix generated a negative expected return over the last 90 days
Augmedix has high historical volatility and very poor performance
Augmedix may become a speculative penny stock
Augmedix has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 26.52 M. Net Loss for the year was (21.69 M) with profit before overhead, payroll, taxes, and interest of 10.01 M.
Augmedix currently holds about 29.99 M in cash with (19.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8.
Roughly 62.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Sale by Mckesson Ventures Llc of 720 shares of Augmedix
Please continue to Trending Equities. Note that the Augmedix information on this page should be used as a complementary analysis to other Augmedix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Augmedix Stock analysis

When running Augmedix price analysis, check to measure Augmedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Augmedix is operating at the current time. Most of Augmedix's value examination focuses on studying past and present price action to predict the probability of Augmedix's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Augmedix's price. Additionally, you may evaluate how the addition of Augmedix to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Is Augmedix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Augmedix. If investors know Augmedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Augmedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Augmedix is measured differently than its book value, which is the value of Augmedix that is recorded on the company's balance sheet. Investors also form their own opinion of Augmedix's value that differs from its market value or its book value, called intrinsic value, which is Augmedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Augmedix's market value can be influenced by many factors that don't directly affect Augmedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Augmedix's value and its price as these two are different measures arrived at by different means. Investors typically determine Augmedix value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Augmedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.